ArticleBMC primary care2026
Building capacity for equitable cervical cancer screening and follow-up in an FQHC-NCI cancer center partnership: a mixed-methods study of multilevel implementation determinants.
Article in BMC primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMultilevel barriers to cervical cancer screening and follow-up contribute to persistent inequities in cancer burden in communities that face social and structural disadvantage. Partnerships between NCI-designated cancer centers and Federally Qualified Health Centers (FQHCs) can strengthen primary care capacity to improve cervical cancer screening uptake, timely follow-up care, and regional cancer control.
methodsThrough the HRSA Accelerating Cancer Screening program, the USC Norris Comprehensive Cancer Center partnered with Chinatown Service Center, a multi-site FQHC serving Chinese and Hispanic patients in Los Angeles, to improve access to cervical cancer screening, follow-up and referral to treatment. Guided by the Consolidated Framework for Implementation Research, we conducted a mixed-methods assessment that combined surveys and semi-structured interviews with clinic team members to identify multilevel determinants of care processes and implementation priorities and a medical chart review to assess screening follow-up patterns among patients screened between January 2020 and March 2023.
resultsSurveys (n = 24) showed providers had higher knowledge of screening guidelines (67% vs. 49%; p < 0.05) and greater confidence discussing cervical cancer with patients (94% vs. 36%; p < 0.05) than clinic staff, indicating opportunities for staff training. Qualitative interviews (n = 23) identified inner setting barriers such as provider variation screening guidelines adherence and lack of tracking tools for screening follow-up. Outer setting barriers included wait times for referrals, transportation barriers, and difficulty accessing specialists through managed care networks. Inner setting factors included FQHC strengths in community partnerships that can contribute to addressing cultural barriers and patients' social needs. Building capacity for tracking cervical cancer screening results was needed. At the individual level, many patients requested gender and language-concordant providers for screening. Older patients and those not sexually active often declined screening. Medical chart reviews (n = 50) identified opportunities to improve closed-loop communication with specialists and to systematically document screening results and risk-based follow-up. DISCUSSION: We found that cervical cancer screening and follow-up strategies should prioritize strengthening workforce capacity, building infrastructure for tracking screening and follow-up, and improving referral coordination. Strengthening partnerships between FQHCs and comprehensive cancer centers offers a scalable approach to disseminating and sustaining innovations in cancer screening, with potential to improve access, adherence, and early detection across populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.